spacer
home > pmps > summer 2019 > leaving on a jet plane
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Leaving on a Jet Plane

‘Leaving on a jet plane’ is the title of one of John Denver’s greatest hits. However, it is also what an increasing number of pharmaceutical products do every day, when the results of Medicon Valley based R&D, commercialisation, and manufacturing are sent out to make a difference worldwide.

The binational Danish-Swedish life sciences cluster Medicon Valley consists of the Region Zealand, the Danish Capital Region, and the Swedish region Skåne. It is not only host to cutting-edge public and private life sciences R&D in, for instance, oncology, dermatology, diabetes, fertility, and CNS-related diseases, but also the world’s largest insulin manufacturing site owned by Novo Nordisk and located in the Danish city of Kalundborg. Additionally, Medicon Valley-based companies such as LEO Pharma, Baxter, Coloplast, Ferring, and Lundbeck have substantial local production and/or R&D facilities; this makes Copenhagen Airport a central logistics hub and, since it serves Denmark and South Sweden alike, the most important airport in the Nordics from a life sciences perspective.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Petter Hartman is the CEO of Medicon Valley Alliance since June 2015 and holds a Masters in Political Science from the University of Lund, Sweden. At Medicon Valley Alliance, Petter is involved in future strategies for the Medicon Valley region, general management within the public sector, project management, and pharma R&D. Petter comes from a post as Funding Manager at Medicon Valley Alliance. Prior to joining, Petter worked for the Secretariat for Interreg IV A Öresund-Kattegat- Skagerrak, Copenhagen, as a project consultant with special responsibility for issues concerning cross-border relations and labourmarket integration projects.
spacer
Petter Hartman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement